These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17904762)

  • 1. Properties of the amniotic membrane may be applicable in cancer therapy.
    Seo JH; Kim YH; Kim JS
    Med Hypotheses; 2008; 70(4):812-4. PubMed ID: 17904762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited.
    Loges S; Mazzone M; Hohensinner P; Carmeliet P
    Cancer Cell; 2009 Mar; 15(3):167-70. PubMed ID: 19249675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein C and its inhibitor in malignancy.
    Suzuki K; Hayashi T
    Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer effects of human amniotic membrane and its epithelial cells.
    Niknejad H; Yazdanpanah G
    Med Hypotheses; 2014 Apr; 82(4):488-9. PubMed ID: 24556192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
    Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does ionizing radiation stimulate cancer invasion and metastasis?
    Madani I; De Neve W; Mareel M
    Bull Cancer; 2008 Mar; 95(3):292-300. PubMed ID: 18390409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy.
    Beecken WD; Engl T; Jonas D; Blaheta RA
    Int J Mol Med; 2009 Feb; 23(2):261-6. PubMed ID: 19148551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ion channels and the hallmarks of cancer.
    Prevarskaya N; Skryma R; Shuba Y
    Trends Mol Med; 2010 Mar; 16(3):107-21. PubMed ID: 20167536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human amniotic epithelial cells induce apoptosis of cancer cells: a new anti-tumor therapeutic strategy.
    Niknejad H; Khayat-Khoei M; Peirovi H; Abolghasemi H
    Cytotherapy; 2014 Jan; 16(1):33-40. PubMed ID: 24113429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Angiogenesis and cancer].
    Bikfalvi A; Javerzat S; Perollet C; Savona C
    Bull Cancer; 1997 Sep; 84(9):885-90. PubMed ID: 9435811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of angiogenesis in tumor growth dynamics].
    Radzikowski C; Opolski A; Wietrzyk J
    Postepy Hig Med Dosw; 1998; 52(6):553-76. PubMed ID: 10093476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation.
    Rupertus K; Dahlem C; Menger MD; Schilling MK; Kollmar O
    Ann Surg Oncol; 2009 Sep; 16(9):2629-37. PubMed ID: 19551445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic antithrombin.
    O'Reilly MS
    Semin Thromb Hemost; 2007 Oct; 33(7):660-6. PubMed ID: 18000792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local proteolytic activity in tumor cell invasion and metastasis.
    Ludwig T
    Bioessays; 2005 Nov; 27(11):1181-91. PubMed ID: 16237672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoxygenase metabolism: roles in tumor progression and survival.
    Pidgeon GP; Lysaght J; Krishnamoorthy S; Reynolds JV; O'Byrne K; Nie D; Honn KV
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):503-24. PubMed ID: 17943411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis, stimulation of cell-cycle arrest and inhibition of angiogenesis make human amnion-derived cells promising sources for cell therapy of cancer.
    Niknejad H; Yazdanpanah G; Ahmadiani A
    Cell Tissue Res; 2016 Mar; 363(3):599-608. PubMed ID: 26846225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
    Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.